Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Emgality

PharmaCompass

01

Brand Name : Emgality

Galcanezumab

arrow
Antibody Engineering
Not Confirmed

Brand Name : Emgality

arrow
Antibody Engineering
Not Confirmed

Galcanezumab

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 363

2019 Revenue in Millions : 163

Growth (%) : 123

blank

02

Brand Name : Emgality

Galcanezumab

arrow
Antibody Engineering
Not Confirmed

03

Brand Name : Emgality

Galcanezumab

arrow
Antibody Engineering
Not Confirmed

04

Brand Name : Emgality

Galcanezumab

arrow
Antibody Engineering
Not Confirmed

Brand Name : Emgality

arrow
Antibody Engineering
Not Confirmed

Galcanezumab

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 45

2021 Revenue in Millions : 39

Growth (%) : 17

blank

05

Brand Name : Emgality

Galcanezumab

arrow
Antibody Engineering
Not Confirmed

06

Brand Name : Emgality

Galcanezumab

arrow
Antibody Engineering
Not Confirmed

Brand Name : Emgality

arrow
Antibody Engineering
Not Confirmed

Galcanezumab

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 49

2022 Revenue in Millions : 45

Growth (%) : 22

blank

07

Brand Name : Emgality

Galcanezumab

arrow
Antibody Engineering
Not Confirmed

Brand Name : Emgality

arrow
Antibody Engineering
Not Confirmed

Galcanezumab

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 163

2018 Revenue in Millions : 5

Growth (%) : 3,216

blank